Table 4 Lists the antigenicity, sensitization, and toxicity of these B-cell linear epitopes.

From: Design of a multi-Epitope mRNA vaccine against Brucella type IV secretion system using reverse vaccinology and immunogenicity approaches

 

Sequence

Peptide length

Start position

Score

Antigenicity

Allergenicity

Toxicity

VirB2

IVSIAAIEPNLAHANG

16

23

0.72

0.9518

NON-ALLERGEN

Non-Toxin

VirB3

SVWISMFILPLIVPIV

16

49

0.54

1.3345

NON-ALLERGEN

Non-Toxin

 

APQESNARSAGYRGDP

16

4

0.75

1.0836

NON-ALLERGEN

Non-Toxin

VirB6

TIYQTLDNSLGKGWNI

16

113

0.89

0.9338

NON-ALLERGEN

Non-Toxin

 

SGSSGGGGSGSAKAGG

16

305

0.89

3.9762

NON-ALLERGEN

Non-Toxin

BtpA

FFSKQWPARELDGLTA

16

183

0.76

0.7899

NON-ALLERGEN

Non-Toxin

 

SELERATRDGAAIGKK

16

32

0.83

0.6645

NON-ALLERGEN

Non-Toxin